1 |
Cruz-nova P, Ocampo-garcía B, Carrión-estrada DA, Briseño-diaz P, Ferro-flores G, Jiménez-mancilla N, Correa-basurto J, Bello M, Vega-loyo L, Thompson-bonilla MDR, Hernández-rivas R, Vargas M. 131I-C19 Iodide Radioisotope and Synthetic I-C19 Compounds as K-Ras4B–PDE6δ Inhibitors: A Novel Approach against Colorectal Cancer—Biological Characterization, Biokinetics and Dosimetry. Molecules 2022;27:5446. [DOI: 10.3390/molecules27175446] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
2 |
Cruz-nova P, Ancira-cortez A, Ferro-flores G, Ocampo-garcía B, Gibbens-bandala B. Controlled-Release Nanosystems with a Dual Function of Targeted Therapy and Radiotherapy in Colorectal Cancer. Pharmaceutics 2022;14:1095. [DOI: 10.3390/pharmaceutics14051095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Abbasi H, Rahbar N, Kouchak M, Khalil Dezfuli P, Handali S. Functionalized liposomes as drug nanocarriers for active targeted cancer therapy: a systematic review. J Liposome Res 2021;:1-16. [PMID: 33729077 DOI: 10.1080/08982104.2021.1903035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
4 |
Chen YL, Wang Q. Synthesis and Structure of α-Aminophosphate and Its Interaction with DNA/BSA. J Appl Spectrosc 2019;86:955-60. [DOI: 10.1007/s10812-019-00921-2] [Reference Citation Analysis]
|
5 |
Zhang R, Zhang Y, Tan J, Wang H, Zhang G, Li N, Meng Z, Zhang F, Chang J, Wang R. Antitumor Effect of 131I-Labeled Anti-VEGFR2 Targeted Mesoporous Silica Nanoparticles in Anaplastic Thyroid Cancer. Nanoscale Res Lett 2019;14:96. [PMID: 30874973 DOI: 10.1186/s11671-019-2924-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
|
6 |
Avvakumova S, Pandolfi L, Soprano E, Moretto L, Bellini M, Galbiati E, Rizzuto MA, Colombo M, Allevi R, Corsi F, Sánchez Iglesias A, Prosperi D. Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells. Nanoscale Adv 2019;1:3626-38. [DOI: 10.1039/c9na00241c] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
7 |
Li W, Sun D, Li N, Shen Y, Hu Y, Tan J. Therapy of cervical cancer using 131I-labeled nanoparticles. J Int Med Res 2018;46:2359-70. [PMID: 29658363 DOI: 10.1177/0300060518761787] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
8 |
Song G, Cheng L, Chao Y, Yang K, Liu Z. Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy. Adv Mater 2017;29. [PMID: 28643452 DOI: 10.1002/adma.201700996] [Cited by in Crossref: 364] [Cited by in F6Publishing: 386] [Article Influence: 60.7] [Reference Citation Analysis]
|
9 |
Marion-Letellier R, Bohn P, Modzelewski R, Vera P, Aziz M, Guérin C, Savoye G, Savoye-Collet C. SPECT-computed tomography in rats with TNBS-induced colitis: A first step toward functional imaging. World J Gastroenterol 2017; 23(2): 216-223 [PMID: 28127195 DOI: 10.3748/wjg.v23.i2.216] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
10 |
Gao J, Fang L, Sun D, Shen Y, Hu Y, Li N, Chang J, Li W, Tan J. 131I-labeled and DOX-loaded multifunctional nanoliposomes for radiotherapy and chemotherapy in brain gliomas. Brain Res 2020;1739:145218. [PMID: 28011394 DOI: 10.1016/j.brainres.2016.12.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
11 |
Wang Q, Yang L, Ding H, Chen X, Wang H, Tang X. Synthesis, X-ray crystal structure, DNA/protein binding and cytotoxicity studies of five α-aminophosphonate N-derivatives. Bioorg Chem 2016;69:132-9. [PMID: 27816796 DOI: 10.1016/j.bioorg.2016.10.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|